STAT5-IN-1 is a potent and selective inhibitor of the STAT5 signaling pathway, which plays a critical role in cell proliferation, survival, and differentiation. It is primarily used in research settings to study the function of STAT5 in various biological processes, especially in hematopoietic and immune cells. Due to its ability to suppress aberrant STAT5 activation, it has been investigated for its potential in oncology research, particularly in cancers driven by dysregulated JAK-STAT signaling such as leukemias and lymphomas. It helps in understanding the mechanistic role of STAT5 in tumor growth and resistance to therapy. Additionally, STAT5-IN-1 serves as a tool compound for validating STAT5 as a therapeutic target and for screening combination treatment strategies in preclinical models.